C21 · Pharmaceuticals · Global
Cell and gene therapy venture capital and public funding deal count
Global: 96 in 2023, −1.0% on 2022.
- 96 Latest · Global · 2023
- −1.0% vs 2022
- Annual Release cadence
- 3 Records · 1 region · 2021–2023
Verified 15 Sep 2026 · 1 publisher · Next period 2024
Over time
Global over time. Forecasts are dashed with hollow markers; the underlying values are one click away under the chart.
Cell and gene therapy venture capital and public funding deal count
Global, 2021 to 2023
Every record
3 records · 1 region · 2021–2023. Each period links to its record: the value, its source evidence and original document.
Download this data
Every file carries its provenance: the CSV has a source column per row, and the chart images print the publisher, the licence and this page's address under the drawing. Source: IQVIA. Licence: CC BY 4.0.
Embed this chart
For automatic sizing and multiple charts, see the JavaScript embed guide.
Free to embed anywhere, including commercially. The attribution bar is part of the chart. The link under the frame is optional: keep it, remove it or mark it rel="nofollow".
Use and publication rights
- View, cite and link: free
Quote any number, cite this page or a single record, and link to it anywhere.
- Copy, chart and republish: free with attribution
The data is published under CC BY 4.0, commercial use included. Credit StatOrigin and the original publisher (IQVIA); the chart files already carry that line.
- The source documents: the publisher's terms
Figures are facts read from the publishers' own documents. The documents themselves, their text and design, stay under each publisher's terms; follow the source links for those.
How this measure is built
- Definition
- Number of venture capital and public funding transactions for cell and gene therapies in a given year.
- Measure
- One slice of Venture and public funding deals ( form: count, segment: cell and gene therapy ) . Total number of venture capital and public funding transactions completed. Region and period are columns on every record, not slices.
- Limitations
- Values are shown as published; StatOrigin does not revise, fill gaps or convert currencies.
- Verification
- Each value, unit, period and place was checked against its source evidence before publication. See the methodology and the corrections process.
Sources · 1 document
| Document | Publisher | Published | Data points |
|---|---|---|---|
| Strengthening Pathways for Cell and Gene Therapies: Current State and Future Scenarios | IQVIA | — | 3 |
Other slices of venture and public funding deals
- Cell and gene therapy venture funding deal count year-over-year change 2 cell and gene therapy
Frequently asked questions
What is the latest cell and gene therapy venture capital and public funding deal count?
Global: 96 in 2023, −1.0% on 2022.
Where does this data come from?
From 1 document published by IQVIA. Every figure on this page links to its record, which preserves the original source evidence.
How often is it updated?
Annual. The newest published period is 2023; the next release should cover 2024. A new figure appears here once the publisher releases it and it passes verification.
Can I use this data?
Yes. StatOrigin publishes it under CC BY 4.0: you may copy, chart and republish it, including commercially, with attribution to StatOrigin and to the original publisher.
Cite this page
Cite the page as a data set, or open any record to cite one figure: each record carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.
StatOrigin. (2026). Cell and gene therapy venture capital and public funding deal count [Data set]. Retrieved October 28, 2026, from https://statorigin.org/indicators/cell-and-gene-therapy-venture-capital-and-public-funding-deal-count
"Cell and gene therapy venture capital and public funding deal count." StatOrigin, 2026, https://statorigin.org/indicators/cell-and-gene-therapy-venture-capital-and-public-funding-deal-count. Accessed 28 Oct. 2026.
StatOrigin. "Cell and gene therapy venture capital and public funding deal count." Data set, 2026. Accessed October 28, 2026. https://statorigin.org/indicators/cell-and-gene-therapy-venture-capital-and-public-funding-deal-count.
@misc{statorigin_cell_and_gene_therapy_venture_capital_and_public_funding_deal_count_2026, title = {Cell and gene therapy venture capital and public funding deal count}, author = {{StatOrigin}}, year = {2026}, url = {https://statorigin.org/indicators/cell-and-gene-therapy-venture-capital-and-public-funding-deal-count}, note = {Data set. Accessed 2026-10-28} }